All Stories

  1. Differences in time to drug initiation and inactive disease achievement by insurance type in patients with nonsystemic juvenile idiopathic arthritis
  2. Metformin for overweight and obese children and adolescents with bipolar spectrum and related mood disorders treated with second-generation antipsychotics: a randomised, pragmatic trial
  3. Stabilizing the Unstable: An Analysis of The Society of Thoracic Surgeons Congenital Heart Surgery Database of Children Supported With Extracorporeal Membrane Oxygenation Before Cardiac Surgery
  4. The Renal Activity Index for Lupus: Validation for Prediction of Kidney Inflammation in Adult Patients with Lupus Nephritis
  5. The Renal Activity Index for Lupus Identifies Active Renal Disease and Treatment Response in Adult Patients With Systemic Lupus Erythematosus and Lupus Nephritis
  6. Giving Resources to lOw‐income Children to Enhance RecoverY (GROCERY): Protocol for a randomized control trial
  7. Development and Validation of Multiplex Assays for Lupus Nephritis Activity Biomarkers
  8. Pharmacokinetics, effectiveness, tolerability and effect on quality of life of open-label tofacitinib for the treatment of moderately active mucocutaneous manifestations of SLE: results of a 76-week phase II study
  9. Neighborhood Socioeconomic Deprivation and Length of Stay in Children With Medical Complexity
  10. Outcomes of a randomized controlled trial of neuromuscular training with real-time biofeedback in young female athletes
  11. Effects of azithromycin in young adults with cystic fibrosis: a protocol for emulating a published randomised controlled trial using registry data
  12. Comparative Effectiveness and Safety of the JAK Inhibitors and Biologic Disease‐Modifying Antirheumatic Drugs in Treating Children With Nonsystemic Juvenile Idiopathic Arthritis: A Bayesian Meta‐Analysis of Randomized Controlled Trials
  13. Outcomes in Children Who Undergo Postcardiotomy Extracorporeal Membrane Oxygenation: A Report From the STS-CHSD
  14. Implementation of the Lupus Low Disease Activity State in Pediatric Rheumatology Care: The Role of the Visual Analog Scale
  15. Digital health technology to support patient-centered shared decision making at point of care for juvenile idiopathic arthritis
  16. Biomarker Changes in Response to Tofacitinib Treatment in Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis
  17. A simple nonparametric least-squares-based causal inference for heterogeneous treatment effects
  18. Association Between Gender and Salary Among Pediatric Hospital Medicine Physicians
  19. Evaluation of diagnostic accuracy of urine neutrophil gelatinase-associated lipocalin in patients with symptoms of urinary tract infections: a meta-analysis
  20. Risk subgroups and intervention effects among infants at high risk for peanut allergy: A model for clinical decision making
  21. External Validation of a Urinary Biomarker Risk Score for the Prediction of Steroid Responsiveness in Adults With Nephrotic Syndrome
  22. Garnering effective telehealth to help optimize multidisciplinary team engagement (GET2HOME) for children with medical complexity: Protocol for a pragmatic randomized control trial
  23. An application programming interface implementing Bayesian approaches for evaluating effect of time-varying treatment with R and Python
  24. Bayesian Causal Inference for Observational Studies with Missingness in Covariates and Outcomes
  25. Feasibility of Conducting Comparative Effectiveness Research and Validation of a Clinical Disease Activity Score for Chronic Nonbacterial Osteomyelitis
  26. Metformin for Overweight and Obese Children With Bipolar Spectrum Disorders Treated With Second-Generation Antipsychotics (MOBILITY): Protocol and Methodological Considerations for a Large Pragmatic Randomized Clinical Trial
  27. Usefulness of the lupus low disease activity state as a treatment target in childhood-onset SLE
  28. GPMatch: A Bayesian causal inference approach using Gaussian process covariance function as a matching tool
  29. Urine biomarker score captures response to induction therapy with lupus nephritis
  30. Female donor hearts can improve survival for male pediatric heart transplant recipients
  31. Feasibility of Conducting Comparative Effectiveness Research and Validation of a Clinical Disease Activity Score for Chronic Nonbacterial Osteomyelitis
  32. Identification and Predictors of Age-Relevant and Activity-Relevant Hop Test Targets in Young Athletes After Anterior Cruciate Ligament Reconstruction
  33. Stability of novel urinary biomarkers used for lupus nephritis
  34. Clinical measurement of lupus nephritis activity is inferior to biomarker-based activity assessment using the renal activity index for lupus nephritis in childhood-onset systemic lupus erythematosus
  35. Effect of ischemic time on pediatric heart transplantation outcomes: is it the same for all allografts?
  36. Reductions In Hospitalizations Among Children Referred To A Primary Care–Based Medical-Legal Partnership
  37. The Impact of Macronutrient Intake on Sex Steroids During Onset of Puberty
  38. Dexamethasone Versus Prednisone in Children Hospitalized With Asthma Exacerbation
  39. International Consensus for the Dosing of Corticosteroids in Childhood‐Onset Systemic Lupus Erythematosus With Proliferative Lupus Nephritis
  40. External validation and comparison of risk score models in pediatric heart transplants
  41. Genetic ancestry differences in pediatric asthma readmission are mediated by socioenvironmental factors
  42. Functional Ability and Health‐Related Quality of Life in Randomized Controlled Trials of Tocilizumab in Patients With Juvenile Idiopathic Arthritis
  43. The Association between Sex Hormones, Pubertal Milestones and Benzophenone-3 Exposure, Measured by Urinary Biomarker or Questionnaire
  44. Subgroup causal effect identification and estimation via matching tree
  45. Correction to: Prescribing Patterns and Impact of Factors Associated with Time to Initial Biologic Therapy among Children with Non-systemic Juvenile Idiopathic Arthritis
  46. Prevalence of autoimmune diseases and other associated conditions in children and young adults with juvenile idiopathic arthritis
  47. Prescribing Patterns and Impact of Factors Associated with Time to Initial Biologic Therapy among Children with Non-systemic Juvenile Idiopathic Arthritis
  48. Pubertal Growth, IGF-1, and Windows of Susceptibility: Puberty and Future Breast Cancer Risk
  49. Development and Psychometric Evaluation of the PROMIS Pediatric Pain Intensity Measure in Children and Adolescents with Chronic Pain
  50. Comparative effectiveness and persistence of TNFi and non-TNFi in juvenile idiopathic arthritis: a large paediatric rheumatology centre in the USA
  51. Onset of Puberty: Mother Knows Best
  52. Early detection of high disease activity in juvenile idiopathic arthritis by sequential monitoring of patients' health‐related quality of life scores
  53. Timing matters: real-world effectiveness of early combination of biologic and conventional synthetic disease-modifying antirheumatic drugs for treating newly diagnosed polyarticular course juvenile idiopathic arthritis
  54. Comparative Effectiveness Research Using Electronic Health Records Data: Ensure Data Quality
  55. Quality of Care in Childhood-onset Systemic Lupus Erythematosus: Report of an Intervention to Improve Cardiovascular and Bone Health Screening
  56. Discharge Medical Complexity, Change in Medical Complexity and Pediatric 30‐day Readmission
  57. Impact of Pubertal Maturation and Chronologic Age on Sex Steroids in Peripubertal Girls
  58. Can’t see the wood for the trees: confounders, colliders and causal inference - a statistician’s approach
  59. Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti–Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discont...
  60. New Method, Same Answer: We Do Not Know if Hypertonic Saline Helps Bronchiolitis
  61. Urine biomarkers of chronic kidney damage and renal functional decline in childhood-onset systemic lupus erythematosus
  62. Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti-Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease
  63. Creation of a Composite Score to Predict Adnexal Torsion in Children and Adolescents
  64. Risk Factors for Brachial Plexus Birth Injury
  65. High Levels of DEK Autoantibodies in Sera of Patients With Polyarticular Juvenile Idiopathic Arthritis and With Early Disease Flares Following Cessation of Anti–Tumor Necrosis Factor Therapy
  66. Human Papillomavirus Vaccine-Related Risk Perceptions Do Not Predict Sexual Initiation Among Young Women Over 30 Months Following Vaccination
  67. Lack of Concordance in Interrater Scoring of the Provider's Global Assessment of Children With Juvenile Idiopathic Arthritis With Low Disease Activity
  68. Clinical Factors That Predict a Second ACL Injury After ACL Reconstruction and Return to Sport: Preliminary Development of a Clinical Decision Algorithm
  69. The Child Opportunity Index and Disparities in Pediatric Asthma Hospitalizations Across One Ohio Metropolitan Area, 2011-2013
  70. Amphiregulin as a Novel Serum Marker of Puberty in Girls
  71. Characteristics of Pediatric Emergency Revisits After an Asthma-Related Hospitalization
  72. Subgroup finding via Bayesian additive regression trees
  73. Real-time optimized biofeedback utilizing sport techniques (ROBUST): a study protocol for a randomized controlled trial
  74. Using Address Information to Identify Hardships Reported by Families of Children Hospitalized With Asthma
  75. Establishing clinical meaning and defining important differences for Patient-Reported Outcomes Measurement Information System (PROMIS®) measures in juvenile idiopathic arthritis using standard setting with patients, parents, and providers
  76. Substantial Decline in Vaccine-Type Human Papillomavirus (HPV) Among Vaccinated Young Women During the First 8 Years After HPV Vaccine Introduction in a Community
  77. Medical and Social Determinants of Health Associated with Intensive Care Admission for Asthma in Children
  78. Explaining Racial Disparities in Child Asthma Readmission Using a Causal Inference Approach
  79. Human papillomavirus vaccine-related risk perceptions and subsequent sexual behaviors and sexually transmitted infections among vaccinated adolescent women
  80. Areas with High Rates of Police-Reported Violent Crime Have Higher Rates of Childhood Asthma Morbidity
  81. Predicting Health Resilience in Pediatric Type 1 Diabetes: A Test of the Resilience Model Framework
  82. Bone Density and Timing of Puberty in a Longitudinal Study of Girls
  83. The Pharmacy-Level Asthma Medication Ratio and Population Health
  84. Allergen Sensitization Profiles in a Population-Based Cohort of Children Hospitalized for Asthma
  85. Family Hardships and Serum Cotinine in Children With Asthma
  86. Housing Code Violation Density Associated With Emergency Department And Hospital Use By Children With Asthma
  87. Hormone Changes in Peripubertal Girls
  88. Enhancing crossover trial design for rare diseases: Limiting ineffective exposure and increasing study power by enabling patient choice to escape early
  89. Traffic-Related Air Pollution and Asthma Hospital Readmission in Children: A Longitudinal Cohort Study
  90. Routinely Sleeping Away from Home and the Association with Child Asthma Readmission
  91. Clinically Inactive Disease in a Cohort of Children with New-onset Polyarticular Juvenile Idiopathic Arthritis Treated with Early Aggressive Therapy: Time to Achievement, Total Duration, and Predictors
  92. The Acceptability of Incorporating a Youth Smoking Prevention Intervention in the Pediatric Emergency Department
  93. Correction: Taking the Bite Out of Rabies, Putting Teeth Into “One Health”
  94. Role of Financial and Social Hardships in Asthma Racial Disparities
  95. Cotinine in Children Admitted for Asthma and Readmission
  96. Determinants of Health-Related Quality of Life in Children Newly Diagnosed With Juvenile Idiopathic Arthritis
  97. Single parent households and increased child asthma morbidity
  98. The Effect of Rilonacept versus Placebo on Health-Related Quality of Life in Patients with Poorly Controlled Familial Mediterranean Fever
  99. Inequalities in Neighborhood Child Asthma Admission Rates and Underlying Community Characteristics in One US County
  100. Inhaled Tobramycin Effectively Reduces FEV1 Decline in Cystic Fibrosis. An Instrumental Variables Analysis
  101. Early Pubertal Development and Insulin Sensitivity among School-Aged Girls: Mediation Via Adiposity
  102. Clinical Evidence for the Role of Trichomonas vaginalis in Regulation of Secretory Leukocyte Protease Inhibitor in the Female Genital Tract
  103. Geomedicine: Area-Based Socioeconomic Measures for Assessing Risk of Hospital Reutilization Among Children Admitted for Asthma
  104. Rilonacept for Colchicine-Resistant or -Intolerant Familial Mediterranean Fever
  105. Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis
  106. Timing of Stage II Lactogenesis Is Predicted by Antenatal Metabolic Health in a Cohort of Primiparas
  107. Correspondence Between Gonadal Steroid Hormone Concentrations and Secondary Sexual Characteristics Assessed by Clinicians, Adolescents, and Parents
  108. Acceptability of self-testing for trichomoniasis increases with experience
  109. Impact of Maternal Communication About Skin, Cervical, and Lung Cancer Prevention on Adolescent Prevention Behaviors
  110. American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis
  111. The Protective Influence of Family Bonding on Smoking Initiation in Adolescents by Racial/Ethnic and Age Subgroups
  112. The Association of Parental Self-Efficacy and Parent–Youth Connectedness With Youth Smoking Intentions
  113. Biomechanical Measures during Landing and Postural Stability Predict Second Anterior Cruciate Ligament Injury after Anterior Cruciate Ligament Reconstruction and Return to Sport
  114. Pubertal timing and smoking initiation in adolescent females: Differences by race
  115. Evaluating the Proportion of Treatment Effect Explained by a Continuous Surrogate Marker in Logistic or Probit Regression Models
  116. Association of Anxiety and Depressive Symptoms and Adiposity Among Adolescent Females, Using Dual Energy X-ray Absorptiometry
  117. Agreement Between Parents and Youths on Measures of Antismoking Socialization
  118. Body Mass Index and Waist-to-Height Changes During Teen Years in Girls Are Influenced by Childhood Body Mass Index
  119. Determination of Relative Timing of Pubertal Maturation through Ordinal Logistic Modeling: Evaluation of Growth and Timing Parameters
  120. The measurement of menstrual symptoms
  121. Depression and Anxiety in Adolescent Females: The Impact of Sleep Preference and Body Mass Index
  122. Mothers' Intention for Their Daughters and Themselves to Receive the Human Papillomavirus Vaccine: A National Study of Nurses
  123. Effects of lifestyle on micronuclei frequency in human lymphocytes in Japanese hard-metal workers
  124. Salivary gonadal and adrenal hormone differences in boys and girls with and without disruptive behavior disorders: Contextual variants
  125. Menstrual Symptoms in Adolescent Girls: Association with Smoking, Depressive Symptoms, and Anxiety
  126. Association of Depressive Symptoms and Anxiety With Bone Mass and Density in Ever-Smoking and Never-Smoking Adolescent Girls
  127. Pubarche as Well as Thelarche May Be a Marker for the Onset of Puberty
  128. Biochemical markers of bone turnover associated with calcium supplementation in children with juvenile rheumatoid arthritis: Results of a double‐blind, placebo‐controlled intervention trial
  129. Functional Regulatory T Cells Accumulate in Aged Hosts and Promote Chronic Infectious Disease Reactivation
  130. Rates of Human Papillomavirus Vaccination, Attitudes About Vaccination, and Human Papillomavirus Prevalence in Young Women
  131. Patterns and Determinants of Physical Activity in U.S. Adolescents
  132. An Emergency Department Intervention to Increase Parent-Child Tobacco Communication: A Pilot Study
  133. Differences in Endocrine Parameters and Psychopathology in Girls with Premature Adrenarche versus On-time Adrenarche
  134. Predicting Sexual Initiation in a Prospective Cohort Study of Adolescents
  135. Perceived Socioeconomic Status: A New Type of Identity That Influences Adolescents’ Self-Rated Health
  136. Impaired reproductive fitness in mothers of children with juvenile autoimmune arthropathies
  137. A randomized controlled trial of calcium supplementation to increase bone mineral density in children with juvenile rheumatoid arthritis
  138. 92: Perceived benefits and barriers of physical activity in adolescent females
  139. 6: HPV-related stigma in female adolescents
  140. 6: How do resident competencies change during an adolescent medicine rotation?
  141. 5: Predicting sexual initiation in adolescents
  142. Pubertal correlates in black and white girls
  143. Pediatricians’ intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes
  144. Attitudes about Human Papillomavirus Vaccine among Family Physicians
  145. ED environmental tobacco smoke counseling
  146. Acceptability of human papillomavirus self testing in female adolescents
  147. Adolescent Use of the Monthly Contraceptive Injection
  148. Outcome of low birthweight in China: A 16‐year longitudinal study
  149. Coercive sexual experiences and subsequent human papillomavirus infection and squamous intraepithelial lesions in adolescent and young adult women
  150. Human papillomavirus infection in urban female adolescents
  151. Does resident communication improve during an adolescent medicine rotation?
  152. Family physicians’ attitudes about HPV vaccines
  153. Patterns of clinical remission in select categories of juvenile idiopathic arthritis
  154. Social Inequalities in Biomarkers of Cardiovascular Risk in Adolescence
  155. Development of a scale to measure adolescents' beliefs and attitudes about postponing sexual initiation
  156. Contrasting prevalence of and demographic disparities in the World Health Organization and National Cholesterol Education Program Adult Treatment Panel III definitions of metabolic syndrome among adolescents
  157. Comparison of Adolescent and Young Adult Self-Collected and Clinician-Collected Samples for Human Papillomavirus
  158. Weight gain, adiposity, and eating behaviors among adolescent females on depot medroxyprogesterone acetate (DMPA)
  159. Statistical assessment of mediational effects for logistic mediational models
  160. Measuring child maltreatment: A comparison of prospective parent reports and retrospective adolescent reports.
  161. The Public Health Impact of Socioeconomic Status on Adolescent Depression and Obesity
  162. A multilevel analysis of the relation of socioeconomic status to adolescent depressive symptoms: does school context matter?
  163. Evaluating Adolescents in Juvenile Detention Facilities for Urogenital Chlamydial Infection
  164. Predictors of papanicolaou smear return in a hospital-based adolescent and young adult clinic
  165. Sexual behaviour of adolescents in Nigeria: cross sectional survey of secondary school students
  166. Socioeconomic Status, Depressive Symptoms, and Adolescent Substance Use
  167. How much does socioeconomic status matter to adolescent health?
  168. Sexual behavior among adolescents in Nigeria
  169. Predictors of weight gain among adolescent females on depomedroxyprogesterone acetate (DMPA)
  170. Socioeconomic status, depression, and health service utilization among adolescent women
  171. Adolescents' Perceptions of Social Status: Development and Evaluation of a New Indicator
  172. Adoption as a Risk Factor for Attempted Suicide During Adolescence
  173. Intention to Return for Papanicolaou Smears in Adolescent Girls and Young Women